These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12795784)

  • 1. Use of pharmacoeconomics in prescribing research. Part 3: Cost-effectiveness analysis--a technique for decision-making at the margin.
    Lopert R; Lang DL; Hill SR
    J Clin Pharm Ther; 2003 Jun; 28(3):243-9. PubMed ID: 12795784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
    Robertson J; Lang D; Hill S
    J Clin Pharm Ther; 2003 Feb; 28(1):73-9. PubMed ID: 12605622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoeconomics.
    Ahuja J; Gupta M; Gupta AK; Kohli K
    Natl Med J India; 2004; 17(2):80-3. PubMed ID: 15141600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacoeconomics: determining the value of drug therapy.
    Peterson C
    Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751
    [No Abstract]   [Full Text] [Related]  

  • 5. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II.
    Garrison LP; Mansley EC; Abbott TA; Bresnahan BW; Hay JW; Smeeding J
    Value Health; 2010; 13(1):8-13. PubMed ID: 19883405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for performing a pharmacoeconomic analysis.
    Jolicoeur LM; Jones-Grizzle AJ; Boyer JG
    Am J Hosp Pharm; 1992 Jul; 49(7):1741-7. PubMed ID: 1621734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis and the formulary decision-making process.
    Wang Z; Salmon JW; Walton SM
    J Manag Care Pharm; 2004; 10(1):48-59. PubMed ID: 14720105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on hospital drug cost control based on the perspective of pharmaceutical economy.
    Xiu Y; Jia L; Chen J; Cui W
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1057-1062. PubMed ID: 28671081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pharmacoeconomics in prescribing research. Part 4: is cost-utility analysis a useful tool?
    Brinsmead R; Hill S
    J Clin Pharm Ther; 2003 Aug; 28(4):339-46. PubMed ID: 12911687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The defined daily dose as a tool in pharmacoeconomics. Advantages and limitations.
    Clarke KW; Gray D
    Pharmacoeconomics; 1995 Apr; 7(4):280-3. PubMed ID: 10155317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacoeconomics in contemporary medicine].
    Czech M
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():16-9. PubMed ID: 15524007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug cost management in pharmacy management based on pharmacoeconomics: Antimicrobial treatment cases.
    Liu S; He L; Sun L; Wang Y
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1069-1073. PubMed ID: 28671083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serving patient needs while implementing cost effectiveness programs in health care administration.
    Tootelian DH
    Health Mark Q; 1994; 11(3-4):161-73. PubMed ID: 10137013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
    McGhan WF
    Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using pharmacoeconomics to value pharmacotherapy.
    Hay JW
    Clin Pharmacol Ther; 2008 Aug; 84(2):197-200. PubMed ID: 18679182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report--Part VI.
    Shi L; Hodges M; Drummond M; Ahn J; Li SC; Hu S; Augustovski F; Hay JW; Smeeding J
    Value Health; 2010; 13(1):28-33. PubMed ID: 19883403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using pharmaceutical cost analyses for decision making.
    U'Ren NA
    Hosp Cost Manag Account; 1997 Nov; 9(8):1-7. PubMed ID: 10178832
    [No Abstract]   [Full Text] [Related]  

  • 18. [The value of pharmacoeconomics. Introduction].
    Carrera-Hueso FJ
    Farm Hosp; 2011 May; 35 Suppl 2():1-2. PubMed ID: 22553826
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of pharmacoeconomics in health policy and management in Norway.
    Grund J; Husbyn H
    Pharmacoeconomics; 1995 Jun; 7(6):475-83. PubMed ID: 10155333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement].
    Hoomans T; van der Roer N; Severens JL; Delwel GO
    Ned Tijdschr Geneeskd; 2010; 154():A958. PubMed ID: 20699045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.